Your browser doesn't support javascript.
loading
Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece.
Gourzoulidis, George; Barmpouni, Myrto; Kossyvaki, Vasiliki; Vietri, Jeffrey; Tzanetakos, Charalampos.
Affiliation
  • Gourzoulidis G; Health Through Evidence, Athens, Greece.
  • Barmpouni M; Pfizer Hellas, Athens, Greece.
  • Kossyvaki V; Pfizer Hellas, Athens, Greece.
  • Vietri J; Pfizer Inc., Collegeville, PA, United States.
  • Tzanetakos C; Health Through Evidence, Athens, Greece.
Front Public Health ; 11: 1229524, 2023.
Article in En | MEDLINE | ID: mdl-37841729
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections Limits: Adult / Humans Country/Region as subject: Europa Language: En Journal: Front Public Health Year: 2023 Document type: Article Affiliation country: Greece
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections Limits: Adult / Humans Country/Region as subject: Europa Language: En Journal: Front Public Health Year: 2023 Document type: Article Affiliation country: Greece